Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.

Identifieur interne : 001627 ( PubMed/Corpus ); précédent : 001626; suivant : 001628

Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.

Auteurs : Kathrine Rugbjerg ; S Ren Friis ; Thomas L. J Rgensen ; Beate Ritz ; Lise Korbo ; J Rgen H. Olsen

Source :

RBID : pubmed:20721917

English descriptors

Abstract

It has been suggested that use of nonsteroidal anti-inflammatory drugs (NSAID) protects against Parkinson's disease, although the results are not consistent. We investigated the risk for Parkinson's disease in patients with osteoarthritis, who are typically intensive users of NSAID. By using the files of the National Danish Hospital Register for the period 1977-2006, we identified a cohort of 134,176 patients with osteoarthritis severe enough to have required subsequent hip or knee implant surgery. The number of first hospital contacts for Parkinson's disease among cohort members in 1986-2007 was compared with that expected from the age-, gender- and period-specific hospital contact rates of the general Danish population, and standardized incidence ratios (SIRs) and associated 95% confidence intervals (CIs) were derived. Cohort members were also linked to the Danish Cancer Register to estimate the SIRs for colorectal and lung cancer. We observed a slightly increased risk for Parkinson's disease among patients with osteoarthritis and subsequent implant surgery (SIR, 1.07; 95% CI, 0.99-1.16). Decreased SIRs were found for both colorectal cancer (0.92; 95% CI, 0.88-0.97), consistent with a high prevalence of NSAID use among cohort members, and lung cancer (0.77; 95% CI, 0.73-0.80), indicating a lower prevalence of smoking than usual. Our results do not support the hypothesis that patients with prolonged use of NSAID and other analgesics are at reduced risk for Parkinson's disease. A possible lower smoking prevalence among patients with osteoarthritis might explain the slightly increased risk for Parkinson's disease.

DOI: 10.1002/mds.23274
PubMed: 20721917

Links to Exploration step

pubmed:20721917

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.</title>
<author>
<name sortKey="Rugbjerg, Kathrine" sort="Rugbjerg, Kathrine" uniqKey="Rugbjerg K" first="Kathrine" last="Rugbjerg">Kathrine Rugbjerg</name>
<affiliation>
<nlm:affiliation>Department of Genetics and Medical Treatment, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. rugbjerg@cancer.dk</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Friis, S Ren" sort="Friis, S Ren" uniqKey="Friis S" first="S Ren" last="Friis">S Ren Friis</name>
</author>
<author>
<name sortKey="J Rgensen, Thomas L" sort="J Rgensen, Thomas L" uniqKey="J Rgensen T" first="Thomas L" last="J Rgensen">Thomas L. J Rgensen</name>
</author>
<author>
<name sortKey="Ritz, Beate" sort="Ritz, Beate" uniqKey="Ritz B" first="Beate" last="Ritz">Beate Ritz</name>
</author>
<author>
<name sortKey="Korbo, Lise" sort="Korbo, Lise" uniqKey="Korbo L" first="Lise" last="Korbo">Lise Korbo</name>
</author>
<author>
<name sortKey="Olsen, J Rgen H" sort="Olsen, J Rgen H" uniqKey="Olsen J" first="J Rgen H" last="Olsen">J Rgen H. Olsen</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.23274</idno>
<idno type="RBID">pubmed:20721917</idno>
<idno type="pmid">20721917</idno>
<idno type="wicri:Area/PubMed/Corpus">001627</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.</title>
<author>
<name sortKey="Rugbjerg, Kathrine" sort="Rugbjerg, Kathrine" uniqKey="Rugbjerg K" first="Kathrine" last="Rugbjerg">Kathrine Rugbjerg</name>
<affiliation>
<nlm:affiliation>Department of Genetics and Medical Treatment, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. rugbjerg@cancer.dk</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Friis, S Ren" sort="Friis, S Ren" uniqKey="Friis S" first="S Ren" last="Friis">S Ren Friis</name>
</author>
<author>
<name sortKey="J Rgensen, Thomas L" sort="J Rgensen, Thomas L" uniqKey="J Rgensen T" first="Thomas L" last="J Rgensen">Thomas L. J Rgensen</name>
</author>
<author>
<name sortKey="Ritz, Beate" sort="Ritz, Beate" uniqKey="Ritz B" first="Beate" last="Ritz">Beate Ritz</name>
</author>
<author>
<name sortKey="Korbo, Lise" sort="Korbo, Lise" uniqKey="Korbo L" first="Lise" last="Korbo">Lise Korbo</name>
</author>
<author>
<name sortKey="Olsen, J Rgen H" sort="Olsen, J Rgen H" uniqKey="Olsen J" first="J Rgen H" last="Olsen">J Rgen H. Olsen</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Analgesics (therapeutic use)</term>
<term>Cohort Studies</term>
<term>Denmark (epidemiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Osteoarthritis (complications)</term>
<term>Osteoarthritis (epidemiology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (etiology)</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Analgesics</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Denmark</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Osteoarthritis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Osteoarthritis</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">It has been suggested that use of nonsteroidal anti-inflammatory drugs (NSAID) protects against Parkinson's disease, although the results are not consistent. We investigated the risk for Parkinson's disease in patients with osteoarthritis, who are typically intensive users of NSAID. By using the files of the National Danish Hospital Register for the period 1977-2006, we identified a cohort of 134,176 patients with osteoarthritis severe enough to have required subsequent hip or knee implant surgery. The number of first hospital contacts for Parkinson's disease among cohort members in 1986-2007 was compared with that expected from the age-, gender- and period-specific hospital contact rates of the general Danish population, and standardized incidence ratios (SIRs) and associated 95% confidence intervals (CIs) were derived. Cohort members were also linked to the Danish Cancer Register to estimate the SIRs for colorectal and lung cancer. We observed a slightly increased risk for Parkinson's disease among patients with osteoarthritis and subsequent implant surgery (SIR, 1.07; 95% CI, 0.99-1.16). Decreased SIRs were found for both colorectal cancer (0.92; 95% CI, 0.88-0.97), consistent with a high prevalence of NSAID use among cohort members, and lung cancer (0.77; 95% CI, 0.73-0.80), indicating a lower prevalence of smoking than usual. Our results do not support the hypothesis that patients with prolonged use of NSAID and other analgesics are at reduced risk for Parkinson's disease. A possible lower smoking prevalence among patients with osteoarthritis might explain the slightly increased risk for Parkinson's disease.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">20721917</PMID>
<DateCreated>
<Year>2010</Year>
<Month>10</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>02</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>09</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>25</Volume>
<Issue>14</Issue>
<PubDate>
<Year>2010</Year>
<Month>Oct</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.</ArticleTitle>
<Pagination>
<MedlinePgn>2355-60</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23274</ELocationID>
<Abstract>
<AbstractText>It has been suggested that use of nonsteroidal anti-inflammatory drugs (NSAID) protects against Parkinson's disease, although the results are not consistent. We investigated the risk for Parkinson's disease in patients with osteoarthritis, who are typically intensive users of NSAID. By using the files of the National Danish Hospital Register for the period 1977-2006, we identified a cohort of 134,176 patients with osteoarthritis severe enough to have required subsequent hip or knee implant surgery. The number of first hospital contacts for Parkinson's disease among cohort members in 1986-2007 was compared with that expected from the age-, gender- and period-specific hospital contact rates of the general Danish population, and standardized incidence ratios (SIRs) and associated 95% confidence intervals (CIs) were derived. Cohort members were also linked to the Danish Cancer Register to estimate the SIRs for colorectal and lung cancer. We observed a slightly increased risk for Parkinson's disease among patients with osteoarthritis and subsequent implant surgery (SIR, 1.07; 95% CI, 0.99-1.16). Decreased SIRs were found for both colorectal cancer (0.92; 95% CI, 0.88-0.97), consistent with a high prevalence of NSAID use among cohort members, and lung cancer (0.77; 95% CI, 0.73-0.80), indicating a lower prevalence of smoking than usual. Our results do not support the hypothesis that patients with prolonged use of NSAID and other analgesics are at reduced risk for Parkinson's disease. A possible lower smoking prevalence among patients with osteoarthritis might explain the slightly increased risk for Parkinson's disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rugbjerg</LastName>
<ForeName>Kathrine</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Genetics and Medical Treatment, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark. rugbjerg@cancer.dk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Friis</LastName>
<ForeName>Søren</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Jørgensen</LastName>
<ForeName>Thomas L</ForeName>
<Initials>TL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ritz</LastName>
<ForeName>Beate</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Korbo</LastName>
<ForeName>Lise</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Olsen</LastName>
<ForeName>Jørgen H</ForeName>
<Initials>JH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>1R40MC08726</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>NS038367</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 ES013717</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 ES013717</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01-ES013717</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03 ES017119</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03 ES017314</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R03-ES017139</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21ES016379</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54ES12078</GrantID>
<Acronym>ES</Acronym>
<Agency>NIEHS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000700">Analgesics</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 2003 Mar 10;88(5):684-8</RefSource>
<PMID Version="1">12618874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2009 Nov 3;73(18):1462-8</RefSource>
<PMID Version="1">19776374</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2003 Aug;60(8):1059-64</RefSource>
<PMID Version="1">12925360</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Neurol. 1987;45:317-21</RefSource>
<PMID Version="1">3493630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dan Med Bull. 1997 Sep;44(4):445-8</RefSource>
<PMID Version="1">9377907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dan Med Bull. 1997 Nov;44(5):535-9</RefSource>
<PMID Version="1">9408738</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 1999 Jan;56(1):33-9</RefSource>
<PMID Version="1">9923759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Dan Med Bull. 1999 Jun;46(3):263-8</RefSource>
<PMID Version="1">10421985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2005 Oct;13(10):942-3</RefSource>
<PMID Version="1">15908236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2005 Dec;58(6):963-7</RefSource>
<PMID Version="1">16240369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2006 Apr 11;66(7):1097-9</RefSource>
<PMID Version="1">16606925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2006 Jul;21(7):964-9</RefSource>
<PMID Version="1">16550541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Mar 6;68(10):764-8</RefSource>
<PMID Version="1">17339584</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Osteoarthritis Cartilage. 2007 Sep;15(9):1097-8</RefSource>
<PMID Version="1">17434763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Nov 6;69(19):1836-42</RefSource>
<PMID Version="1">17984451</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Sep;22 Suppl 17:S343-50</RefSource>
<PMID Version="1">18175395</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 2008 Jan 15;98(1):232-7</RefSource>
<PMID Version="1">18087276</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2007;13 Suppl 3:S211-20</RefSource>
<PMID Version="1">18267238</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Neurosci. 2008 May;15(5):576-7</RefSource>
<PMID Version="1">18343119</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 2008;337:a2494</RefSource>
<PMID Version="1">19074944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2009 Apr 11;373(9671):1301-9</RefSource>
<PMID Version="1">19328542</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Oncol. 2009 May;10(5):501-7</RefSource>
<PMID Version="1">19410194</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cancer Causes Control. 2009 Jul;20(5):731-40</RefSource>
<PMID Version="1">19122977</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drugs Aging. 2009;26(9):769-79</RefSource>
<PMID Version="1">19728750</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Br J Cancer. 2003 Jun 2;88(11):1687-92</RefSource>
<PMID Version="1">12771981</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000700">Analgesics</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D003718">Denmark</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010003">Osteoarthritis</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS207947</OtherID>
<OtherID Source="NLM">PMC2992436</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>2</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1002/mds.23274</ArticleId>
<ArticleId IdType="pubmed">20721917</ArticleId>
<ArticleId IdType="pmc">PMC2992436</ArticleId>
<ArticleId IdType="mid">NIHMS207947</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001627 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001627 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:20721917
   |texte=   Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:20721917" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024